Which funds bought or sold BRKR in Q3 2026?
Bruker Corp. 4 funds bought, 2 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was +$88M.
Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)
- Glenview+$73M
- JennisonNEW+$65M
- Bridgewater+$29M
- PRIMECAP+$6M
- VikingOUT−$54M
- Brown Advisory−$31M
Top 10 each side. NEW = opened a position, OUT = sold the whole position.
Bought (4)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Glenview Hedge fund | Added+446% | +$73M | $89M |
| Jennison Growth / crossover | New | +$65M | $65M |
| Bridgewater Hedge fund | Added+1052.3% | +$29M | $32M |
| PRIMECAP Growth / crossover | Added+9.9% | +$6M | $63M |
Sold (2)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Viking Hedge fund | Sold out | −$54M | — |
| Brown Advisory Asset manager | Trimmed-32.8% | −$31M | $63M |
Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.